Left Atrial Function Changes After Left Atrial Appendage Closure in Patients With Persistent Atrial Fibrillation

Not Applicable

Completed

• Conditions: Atrial Fibrillation
• Interventions: Procedure: LAAC combined with radiofrequency ablation group; Procedure: Left atrial appendage closure; Procedure: Radiofrequency ablation

• Registration Number: NCT03276169
• Lead Sponsor: Ruiqin xie

Brief Summary

A total of 105 patients with persistent atrial fibrillation(AF), that lasting longer than one year and planned to undergo surgical treatment, will be allocated into three groups. These patients will receive left atrial appendage closure(LAAC), radiofrequency ablation under the guidance of 3D mapping and LAAC combined with radiofrequency ablation, respectively (allocation ratio, 1:1:1). Real-time 3D ultrasound and 2D ultrasound examinations and measurement of left ventricle(LV) and left atrial(LA) function are carried out for all patients before the operation, and at 1, 2, 3 and 4 weeks and 2, 3, 6, 9 and 12 months after the operation. All ultrasound data will be stored and a professional director from the ultrasound room will be invited for quantitative analysis. Indicators for ultrasonography include: LV ejection fraction(LVEF), LV end-diastolic volume, Stroke volume, left atrial anterior and posterior diameter, left atrial volume, left atrial volume index, mitral e ", E peak, A peak, velocity time integral (VTI), left atrial ejection fraction, left atrial strain, and strain rate. Blood samples are extracted in all patients to detect type B natriuretic peptide before the operation and at 1, 2, 3 days and 1,3,6,12 months after the operation. Blood samples are extracted in all patients to detect routine blood, coagulation, D-D dimmer,Inflammatory markers (hsCRP） and other biochemical parameters before the operation and at 1, 2, 3 and 4 weeks and 1, 2, 3,6and 12 months after the operation. At the same time in operation LA pressure in all patients will be measured preoperatively and postoperatively. This study will clarify the short-term and long-term changes of LA pressure and function of patients with persistent AF after LAAC, and whether changes in left atrial pressure and function are related to inflammation indicators. This study will also to observe whether the coagulation indexes changed after LAAC that can be used to know whether the LAAC activates the coagulation system. In addition, this study to investigate the effects of radiofrequency ablation combined with LAAC on left atrial pressure and function, changes of blood coagulation and inflammatory markers, and to analyze the above findings. At an average follow-up of one year, changes in left atrial function, inflammation, coagulation, and embolic events were analyzed early (3 months after surgery) and late (1 years after surgery).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-09-01
• Study First Submitted QC: 2017-09-07
• Study First Posted: 2017-09-08
• Study Start: 2017-10-01
• Status Verified: 2020-03
• Primary Completion: 2020-10-01
• Study Completion: 2020-11-01
• Last Update Submitted: 2021-03-17
• Last Update Posted: 2021-03-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

• persistent atrial fibrillation episode occurs in the patient that lasting longer than one year,
• atrial fibrillation cannot be prevented in patients who orally take class I and III antiarrhythmic drugs,
• and patient age is <80 years.

Exclusion Criteria

• patients with previous history of atrial fibrillation ablation, atrial thrombosis, or valvular heart disease (moderate and severe valvular stenosis, severe valvular regurgitation),
• patients who underwent prosthetic heart valve replacement,
• pregnant women,
• patients with existing liver and kidney disease, malignant tumors or hematological system diseases.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
LAAC combined with radiofrequency ablation group	LAAC combined with radiofrequency ablation group	-
Left atrial appendage closure group	Left atrial appendage closure	-
Radiofrequency ablation group	Radiofrequency ablation	-

Primary Outcome Measures

Name	Time	Method
Left atrial function of postoperative left atrial appendage occlusion detected	1-12 month	Transthoracic ultrasound

Secondary Outcome Measures

Name	Time	Method
Plasma biomarkers of inflammation assessed	1-12 month	Blood samples are extracted in all patients for the detection of the C reactive protein, white blood cell，red blood cell, Platelets，neutrophile and lymphocytes.
B natriuretic peptide assessed	1-12 month	Blood samples are extracted in all patients to detected
Coagulation index assessed	1-6 month	Blood samples are extracted in all patients to detected

Trial Locations

Locations (1)

The Second Hospital of Hebei Medical University; 🇨🇳 Shijiazhuang, Hebei, China